These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31404085)

  • 21. [Recent treatment for medication-related osteonecrosis of the jaw].
    Ota Y; Sasaki M
    Clin Calcium; 2016 Apr; 26(4):612-21. PubMed ID: 27013633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
    Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
    Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-Sectional Study of four Serological Bone Turnover Markers for the Risk Assessment of Medication-Related Osteonecrosis of the Jaw.
    Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; König KC; Schultze-Mosgau S
    J Craniofac Surg; 2018 Mar; 29(2):e137-e140. PubMed ID: 29215447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
    Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
    Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection and medication-related osteonecrosis of the jaw.
    Katsarelis H; Shah NP; Dhariwal DK; Pazianas M
    J Dent Res; 2015 Apr; 94(4):534-9. PubMed ID: 25710950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
    Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
    Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment.
    Nicolatou-Galitis O; Schiødt M; Mendes RA; Ripamonti C; Hope S; Drudge-Coates L; Niepel D; Van den Wyngaert T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Feb; 127(2):117-135. PubMed ID: 30393090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal Bleeding in Conjunction with Mandibular Medication-related Osteonecrosis of the Jaw (MRONJ).
    Suzuki T; Sekiya R; Hamada Y; Takahashi M; Karakida K; Sakamoto H
    Bull Tokyo Dent Coll; 2018; 59(1):27-34. PubMed ID: 29563359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further development of the MRONJ minipig large animal model.
    Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.
    Yamada SI; Kurita H; Kondo E; Suzuki S; Nishimaki F; Yoshimura N; Morioka M; Ishii S; Kamata T
    Clin Oral Investig; 2019 Aug; 23(8):3203-3211. PubMed ID: 30406491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw.
    Yahara H; Hiraki A; Maruoka Y; Hirabayashi A; Suzuki M; Yahara K
    PLoS One; 2020; 15(11):e0241676. PubMed ID: 33253207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - A single center cohort study.
    Ristow O; Rückschloß T; Bodem J; Berger M; Bodem E; Kargus S; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2018 May; 46(5):815-824. PubMed ID: 29631942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic comorbidities are associated with medication-related osteonecrosis of the jaws: Case-control study.
    McGowan K; Acton C; Ivanovski S; Johnson NW; Ware RS
    Oral Dis; 2019 May; 25(4):1107-1115. PubMed ID: 30674072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
    Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
    Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study.
    Hallmer F; Andersson G; Götrick B; Warfvinge G; Anderud J; Bjørnland T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Dec; 126(6):477-485. PubMed ID: 30249535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.